Zenotech Laboratories

Zenotech Laboratories Total Assets

The Total Assets of Zenotech Laboratories (532039.BO) as of Oct 30, 2026 is 1.11 B INR. In the previous year, Total Assets was 1.11 B INR — a change of 0.11% (higher).

Total Assets

1.11 BINR

YoY

0.11%

Last updated:

Total Assets of Zenotech Laboratories is 2026 1.11 B INR. Total Assets of Zenotech Laboratories was 2025 1.11 B INR. It decreases by 0.11% higher compared to the previous year.

The Zenotech Laboratories Total Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Total Assets
Date
Total Assets
Jan 1, 2019
845.83 M INR
Jan 1, 2020
855.54 M INR
Jan 1, 2021
858.44 M INR
Jan 1, 2022
940.84 M INR
Jan 1, 2023
1.01 B INR
Jan 1, 2024
1.06 B INR
Jan 1, 2025
1.11 B INR
Jan 1, 2026
1.11 B INR
The Zenotech Laboratories Total Assets history
YEARTotal AssetsYoY
1.11 BINR+0.11%
1.11 BINR+4.54%
1.06 BINR+5.29%
1.01 BINR+7.22%
940.84 MINR+9.60%
858.44 MINR+0.34%
855.54 MINR+1.15%
845.83 MINR+3.48%
817.41 MINR+61.08%
507.47 MINR-4.10%
529.17 MINR-16.99%
637.48 MINR-9.08%
701.17 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zenotech Laboratories Stock analysis

What does Zenotech Laboratories do? Zenotech Laboratories Ltd manufactures and markets pharmaceutical products, specializing in oncology, biotechnology, and general injectables. The company operates from a manufacturing facility in Turkapally village, Shamirpet Mandal, Telangana, producing specialty generic injectables for the pharmaceutical sector. Its products are sold to healthcare providers and distributors within the pharmaceutical industry, targeting markets that require specialized injectable solutions. The firm's business model focuses on the production and distribution of generic injectables, leveraging its facility in Telangana to serve both domestic and international markets. By concentrating on oncology and biotechnology injectables, Zenotech addresses specific medical needs, generating revenue through the sale of these high-demand pharmaceutical products to hospitals, clinics, and pharmaceutical distributors. Zenotech Laboratories Ltd's revenue streams come from the sale of its specialty generic injectables, including oncology and biotechnology products, to healthcare institutions and distribution networks. The company's manufacturing capabilities in Telangana support its role as a supplier in the pharmaceutical supply chain, with a focus on injectable formulations that cater to critical healthcare applications. Zenotech Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zenotech Laboratories stock

Total Assets of Zenotech Laboratories is 1.11 B INR in 2026.

Total Assets of Zenotech Laboratories changed from 1.11 B INR to 1.11 B INR, representing a 0.11% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets Zenotech Laboratories since 2006 – with annual values, charts, and detailed analysis.

Total assets represent everything a company owns, including cash, inventory, property, and intangible assets. It is a key measure of a company's size and resource base.

Total Assets's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Assets's Zenotech Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Zenotech Laboratories

All Key Metrics — Zenotech Laboratories